Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,915 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: jensen r. J Clin Oncol. 2023 Nov 10;41(32):4945-4952. doi: 10.1200/JCO.22.02772. J Clin Oncol. 2023. PMID: 37935104 Clinical Trial.
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G. Hoppe JE, et al. Among authors: jensen r. Lancet Respir Med. 2024 Dec 20:S2213-2600(24)00407-7. doi: 10.1016/S2213-2600(24)00407-7. Online ahead of print. Lancet Respir Med. 2024. PMID: 39756425 Free article.
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H. Mendez JS, et al. Among authors: jensen rl. Neurooncol Adv. 2024 Nov 22;6(1):vdae202. doi: 10.1093/noajnl/vdae202. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39734810 Free PMC article.
Patterns and predictors of multiple sclerosis phenotype transition.
Pontieri L, Greene N, Wandall-Holm MF, Geertsen SS, Asgari N, Jensen HB, Illes Z, Schäfer J, Jensen RM, Sejbæk T, Weglewski A, Mahler MR, Poulsen MB, Prakash S, Stilund M, Kant M, Rasmussen PV, Svendsen KB, Sellebjerg F, Magyari M. Pontieri L, et al. Among authors: jensen rm. Brain Commun. 2024 Nov 23;6(6):fcae422. doi: 10.1093/braincomms/fcae422. eCollection 2024. Brain Commun. 2024. PMID: 39713244 Free PMC article.
3,915 results